Beardsley Robert A 4
4 · Galera Therapeutics, Inc. · Filed Sep 13, 2022
Insider Transaction Report
Form 4
Beardsley Robert A
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option
2022-09-12−10,000→ 85,651 totalExercise: $1.07Exp: 2022-11-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2022-09-12$1.07/sh+10,000$10,700→ 98,191 total
Footnotes (1)
- [F1]The option has fully vested and is currently exercisable.